JAMP RIVASTIGMINE
JAMP PHARMA CORPORATION
Quick answers
Is there a shortage of JAMP RIVASTIGMINE in Canada?
No. There is no current shortage of JAMP RIVASTIGMINE 4.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
EXELON
KNIGHT THERAPEUTICS INC.
PMS-RIVASTIGMINE
PHARMASCIENCE INC
MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
MYLAN-RIVASTIGMINE
MYLAN PHARMACEUTICALS ULC
AURO-RIVASTIGMINE
AURO PHARMA INC
PHL-RIVASTIGMINE
PHARMEL INC
DIN
02485389
Strength
4.5MG
Dosage Form
Capsule
Route
Oral
Active Ingredient
RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
See all RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164